INNO-GENE SA ZY -10 Cash Flow Conversion Efficiency

Latest as of June 2025: 0.003x

INNO-GENE SA ZY -10 cash flow conversion efficiency. Based on the latest financial reports, INNO-GENE SA ZY -10 (WQ3) has a cash flow conversion efficiency ratio of 0.003x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€54.00K ≈ $63.13K USD) by net assets (€17.55 Million ≈ $20.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of INNO-GENE SA ZY -10 (2021–2024)

Cash flow conversion efficiency of INNO-GENE SA ZY -10 from 2021 to 2024. This chart illustrates how INNO-GENE SA ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data. View INNO-GENE SA ZY -10 stock quote for real-time trading data and today's change.

INNO-GENE SA ZY -10 Cash Flow Conversion Ratio Explained

INNO-GENE SA ZY -10 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

INNO-GENE SA ZY -10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INNO-GENE SA ZY -10 ranked by their cash flow conversion efficiency. Also see WQ3 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
INCREDIBLE INDUSTRIES LIMITED NSE:INCREDIBLE	0.022x
Equity Metals Corp V:EQTY	-0.520x
COSMOS HEALTH NEW DL-01 F:V67A	-0.249x
RN2 Technologies Co. Ltd KQ:148250	0.001x
Wellchange Holdings Company Limited NASDAQ:WCT	0.029x
Australian Agricultural Projects Ltd AU:AAP	0.124x
Applied Therapeutics Inc NASDAQ:APLT	32.800x
Dome Gold Mines Ltd AU:DME	-0.023x

Annual Cash Flow Conversion Efficiency for INNO-GENE SA ZY -10 (2021–2024)

The table below shows the annual cash flow conversion efficiency of INNO-GENE SA ZY -10 from 2021 to 2024. Review WQ3 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€18.02 Million ≈ $21.06 Million	€-1.13 Million ≈ $-1.32 Million	-0.063x	+93.85%
2023-12-31	€2.44 Million ≈ $2.85 Million	€-2.49 Million ≈ $-2.91 Million	-1.020x	-74759.14%
2022-12-31	€8.05 Million ≈ $9.41 Million	€11.00K ≈ $12.86K	0.001x	-99.84%
2021-12-31	€7.85 Million ≈ $9.17 Million	€6.75 Million ≈ $7.89 Million	0.861x	--

About INNO-GENE SA ZY -10

F:WQ3 Germany Specialty Chemicals

Market Cap

$14.88 Million

€12.73 Million EUR

Market Cap Rank

#25863 Global

#2215 in Germany

Share Price

€0.38

Change (1 day)

+0.00%

52-Week Range

€0.38 - €0.38

All Time High

€4.46